Stock 4978 REPROCELL INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Company ReproCELL Incorporated

Equities

4978

JP3974770004

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-19 am EDT 		5-day change 1st Jan Change
137 JPY -3.52% Intraday chart for ReproCELL Incorporated -6.80% -21.71%
2023 ReproCELL Incorporated announced that it has received ¥5.3 million in funding from Morgan Stanley MUFG Securities Co., Ltd. CI
2023 ReproCELL Incorporated announced that it expects to receive ¥5.3 million in funding CI

Business Summary

ReproCELL Incorporated is primarily engaged in the development of stem cell technologies. The Company operates its business in two segments. The IPS Cell segment deals with regenerative medicine focused on Human ES (embryonic stem) cells and human iPS (induced pluripotent stem) cells. This segment manufactures research reagents used in human ES / iPS cell research, such as culture fluid, peeling liquid, frozen preservation solution, coating agents and antibody. The Clinical Testing segment clinical testing services that is required by hematopoietic stem cell transplantation and organ transplantation.

Number of employees: 92

Sales per Business

JPY in Million2022Weight2023Weight Delta
Research Support
68.3 %
1,381 61.8 % 2,018 68.3 % +46.14%
Medical
31.7 %
854 38.2 % 936 31.7 % +9.56%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
50.7 %
1,249 55.9 % 1,499 50.7 % +20.00%
United States
27.3 %
509 22.8 % 805 27.3 % +58.22%
United Kingdom
18.6 %
401 17.9 % 549 18.6 % +37.08%
India
3.4 %
76 3.4 % 100 3.4 % +31.60%

Managers

Managers TitleAgeSince
Shigetomo Akano DFI
 Director of Finance/CFO 42 20-11-10
Chikafumi Yokoyama PSD
 President 56 04-06-30
Daisuke Usui COO
 Chief Operating Officer 50 15-08-31

Members of the board

Members of the board TitleAgeSince
Yoshiyuki Yamakawa BRD
 Director/Board Member 61 08-05-31
Chikafumi Yokoyama PSD
 President 56 04-06-30
Daisuke Usui COO
 Chief Operating Officer 50 15-08-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 88,224,691 84,172,185 ( 95.41 %) 72,256 ( 0.0819 %) 95.41 %

Shareholders

NameEquities%Valuation
Chikafumi Yokoyama
1.153 %
1,016,950 1.153 % 1 M ¥
Reprocell Restricted Stock Compensation Plan
1.053 %
929,000 1.053 % 975 989 ¥
Teruo Isohata
0.9335 %
823,600 0.9335 % 865 258 ¥
Toru Nakano
0.6574 %
580,000 0.6574 % 609 336 ¥
Norio Nakatsuji
0.5667 %
500,000 0.5667 % 525 290 ¥
Mamoru Fujii
0.3918 %
345,700 0.3918 % 363 186 ¥
Daisuke Usui
0.1904 %
168,000 0.1904 % 176 497 ¥
COSMO BIO COMPANY,LIMITED
0.1495 %
131,900 0.1495 % 138 572 ¥
EFG Bank AG
0.0510 %
45,000 0.0510 % 47 276 ¥
REPROCELL INCORPORATED
0.0382 %
33,700 0.0382 % 35 405 ¥

Holdings

NameEquities%Valuation
KRINGLE PHARMA, INC.
1.59%
 100,000 1.59% 348,211 $
REPROCELL INCORPORATED
0.04%
 33,700 0.04% 35,405 $

Company contact information

ReproCELL, Inc.

Metlife Shin-Yokohama Building, 9/F 3-8-11 Shin-Yokohama

222-0033, Yokohama

+81 45 475 3887

http://www.reprocell.co.jp
address ReproCELL Incorporated(4978)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Ratings for ReproCELL Incorporated

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
REPROCELL INCORPORATED Stock ReproCELL Incorporated
-21.71% 80.97M
CSL LIMITED Stock CSL Limited
-5.99% 84.46B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+2.76% 40.85B
BIOGEN INC. Stock Biogen Inc.
-25.75% 27.69B
UCB Stock UCB
+53.61% 24.28B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-7.78% 17.09B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-33.74% 13.67B
INCYTE CORPORATION Stock Incyte Corporation
-16.34% 11.86B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-11.19% 11.79B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
-2.25% 8.07B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 4978 Stock
  4. Company ReproCELL Incorporated